Healthcare

Regis Healthcare (ASX:REG) shares climbed after the aged care operator said full-yearEarningsare tracking towards the top end of its guidance range. The update underscores improving sector dynamics, occupancy and pricing, supporting the company'sEarningsmomentum. Investors are reassessing the long-term opportunity in Australian aged care.

Vitrafy Life Sciences Limited (ASX:VFY) has experienced downward pressure in its latestTrading session, with its share price falling 3.26% to $2.08. The decline occurred on relatively low tradingVolumeof 79,240 shares, indicating limitedLiquiditycompared to larger ASX-listed peers.

This article unpacks why 4DMedical has become one of the most talked about names on the Australian stock market, what the new GlaxoSmithKline contract really means and where the risks now sit for investors weighing exposure to this high-growth Australian medical technologyBusiness.

Investors who have long held CSL as a defensive growth name are now asking whether the ASX healthcare giant is facing more pain, or whether the recent weakness represents a reset that could pave the way for a re-rating. The answer depends on how …

Shares of Mesoblast Limited (ASX:MSB) advanced 2.79% during the April 29, 2026Trading session, trading at $2.21 — a gain of $0.06 on the day. TradingVolumereached 736,592 shares, reflecting meaningful investor interest in the session's key announcement. The bid-offer spread settled between $2.210 and $2.220, …

It is important to note that the immediate catalyst for the move in Dimerix Limited (ASX: DXB) was not disclosed in the provided market data. That is a common situation in any given ASX market update, where many single-stock price moves reflect a combination …

It is important to note that the immediate catalyst for the move in Cochlear Limited (ASX: COH) was not disclosed in the provided market data. That is a common situation in any given ASX market update, where many single-stock price moves reflect a combination …